IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma

Journal of Cancer - Australia
doi 10.7150/jca.22915
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Diagnostic Utility of IDH1/2 Mutations to Distinguish Dedifferentiated Chondrosarcoma From Undifferentiated Pleomorphic Sarcoma of Bone

Human Pathology
Forensic MedicinePathology
2017English

Cancer-Associated IDH1 Mutations Produce 2-Hydroxyglutarate

Nature
Multidisciplinary
2009English

Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pelvic Chondrosarcoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

The Combination of NPM1, DNMT3A and IDH1/2 Mutations Leads to Inferior Overall Survival in AML

American Journal of Hematology
Hematology
2019English

IDH1/2 Mutations and BCL-2 Dependence: An Unexpected Chink in AML’s Armour

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Expanding the Spectrum of IDH1 Mutations in Gliomas

Modern Pathology
Forensic MedicinePathology
2013English

Nondisruptive P53 Mutations Are Associated With Shorter Survival in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?

Oncologist
Cancer ResearchMedicineOncology
2010English

Mutations in KRAS Codon 12 Predict Poor Survival in Chinese Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy